Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,103.06
+11.610.55%
Number of Gainers:708
Number of Losers:302
Number of Flat:13
PE:- -
High:2,107.72
Open:2,091.55
Low:2,091.45
Close:2,091.45
Volume:2.48B
Turnover:324.50B
Market Cap:97.82T
Float Cap:91.57T

Loading ...

Jabil Posts Strong Earnings. the Stock Falls Anyway.

Dow Jones
·
Sep 30

Integer Says U.S. Antitrust Waiting Period Ends Early for KKR Deal at USD 127 a Share

Reuters
·
Sep 30

Trio Petroleum Acquires 24 Lloydminster Oil Wells for CDN$ 800,000, Transfers Water Disposal Asset to Marlin Resources

Reuters
·
Sep 30

DarkIris Sets up U.S. Subsidiary to Expand North America Operations

Reuters
·
Sep 30

Airbnb Adds AI Search, More Social Features - TechCrunch

Reuters
·
Sep 30

IBM Study Shows 62% of CFOs Take on Enterprise AI Strategy Leadership

Reuters
·
Sep 30

SEI Names Connall McGuckian Managing Director, Head of Singapore

Reuters
·
Sep 30

Rocket Doctor AI CEO Essam Hamza to Present at NIBA Investment Conference

Reuters
·
Sep 30

ISG Says Brazil Public Agencies Accelerate Digital Modernization Under Fiscal Pressure

Reuters
·
Sep 30

US Equity Futures Mostly Flat Pre-Bell as Traders Await Key Inflation Report

MT Newswires Live
·
Sep 30

Verrica Says Pooled Phase 3 Analysis Shows Ycanth Clears Molluscum About 4x Faster than Vehicle

Reuters
·
Sep 30

Eli Lilly - 77% of Ebglyss Patients Reported Satisfaction with Hand Clearance at Week 16

THOMSON REUTERS
·
Sep 30

Eli Lilly - Ebglyss Monotherapy Meets Primary and Secondary Endpoints at Week 16 in Phase 3B Adtouch Study

THOMSON REUTERS
·
Sep 30

New Phase 3B Data Show Lilly's Ebglyss (Lebrikizumab-Lbkz) Delivered Significant and Rapid Improvements in Skin Clearance, Itch, Pain, and Patient Satisfaction in People with Moderate-to-Severe Hand and Foot Atopic Dermatitis

THOMSON REUTERS
·
Sep 30

Eli Lilly - Treatment-Emergent Adverse Events in 41.8% Ebglyss Patients, 39.6% Placebo, All Mild or Moderate

THOMSON REUTERS
·
Sep 30

Eli Lilly - Submits Ebglyss Adtouch Data to FDA and Plans Global Regulatory Submissions for Label Update

THOMSON REUTERS
·
Sep 30

Genius Group RICO Lawsuit Advances as US Judge Denies Defendants’ Dismissal Bids

Reuters
·
Sep 30

Franklin Templeton Funds BWG, EMD, SCD, WIA, WIW Post September Per-Share Distributions in 19(a) Notices

Reuters
·
Sep 30

HomesToLife 1H 2026 Net Income Drops 39% to Us$6.07 Million; Net Revenue Rises 10% to Us$198.31 Million

Reuters
·
Sep 30

Cycurion CEO Highlights $54.6 Million, 10-Year Contract Win in SmallCapVoice Interview

Reuters
·
Sep 30